Compare Stocks

Comparative Price Performance Over Time

Compare Stocks - Price & Volume

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Bio Nitrogen Hldgs stock logo
BION
Bio Nitrogen Hldgs
$0.00
$0.00
$0.01
N/AN/A158,122 shsN/A
JG Boswell stock logo
BWEL
JG Boswell
$598.99
+0.7%
$593.48
$571.02
$700.00
N/AN/A143 shs28 shs
CERP
Cereplast
$0.00
$0.00
$0.01
N/AN/A11,798 shs225 shs
Clariant AG stock logo
CLZNF
Clariant
$13.97
$13.27
$12.89
$15.70
N/AN/A2,333 shsN/A
Nascent Biotech, Inc. stock logo
NBIO
Nascent Biotech
$0.10
$0.12
$0.03
$0.28
N/AN/A79,815 shsN/A
Elon Musk's Next Move Cover

Wondering when you'll finally be able to invest in SpaceX, StarLink, or The Boring Company? Click the link below to learn when Elon Musk will let these companies finally IPO.

Get This Free Report

Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
JG Boswell stock logo
BWEL
JG Boswell
+0.67%+2.39%0.00%+1.01%-14.43%
Clariant AG stock logo
CLZNF
Clariant
0.00%0.00%+8.35%+6.20%-11.05%
Nascent Biotech, Inc. stock logo
NBIO
Nascent Biotech
0.00%+8.12%-45.85%-22.56%+67.34%

MarketRank™

CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Bio Nitrogen Hldgs stock logo
BION
Bio Nitrogen Hldgs
N/AN/AN/AN/AN/AN/AN/AN/A
JG Boswell stock logo
BWEL
JG Boswell
N/AN/AN/AN/AN/AN/AN/AN/A
CERP
Cereplast
N/AN/AN/AN/AN/AN/AN/AN/A
Clariant AG stock logo
CLZNF
Clariant
N/AN/AN/AN/AN/AN/AN/AN/A
Nascent Biotech, Inc. stock logo
NBIO
Nascent Biotech
N/AN/AN/AN/AN/AN/AN/AN/A

Analyst Ratings

CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Bio Nitrogen Hldgs stock logo
BION
Bio Nitrogen Hldgs
N/AN/AN/AN/A
JG Boswell stock logo
BWEL
JG Boswell
N/AN/AN/AN/A
CERP
Cereplast
N/AN/AN/AN/A
Clariant AG stock logo
CLZNF
Clariant
N/AN/AN/AN/A
Nascent Biotech, Inc. stock logo
NBIO
Nascent Biotech
N/AN/AN/AN/A

Sales & Book Value

CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Bio Nitrogen Hldgs stock logo
BION
Bio Nitrogen Hldgs
N/AN/AN/AN/AN/AN/A
JG Boswell stock logo
BWEL
JG Boswell
N/AN/AN/AN/AN/AN/A
CERP
Cereplast
N/AN/AN/AN/AN/AN/A
Clariant AG stock logo
CLZNF
Clariant
N/AN/AN/AN/AN/AN/A
Nascent Biotech, Inc. stock logo
NBIO
Nascent Biotech
N/AN/AN/AN/AN/AN/A

Profitability & Earnings

CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Bio Nitrogen Hldgs stock logo
BION
Bio Nitrogen Hldgs
N/AN/A0.00N/AN/AN/AN/AN/AN/A
JG Boswell stock logo
BWEL
JG Boswell
N/AN/A0.00N/AN/AN/AN/AN/A
CERP
Cereplast
N/AN/A0.00N/AN/AN/AN/AN/AN/A
Clariant AG stock logo
CLZNF
Clariant
N/A$0.4729.95N/AN/AN/AN/AN/A
Nascent Biotech, Inc. stock logo
NBIO
Nascent Biotech
N/AN/A0.00N/AN/AN/AN/A6/29/2024 (Estimated)

Dividends

CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Bio Nitrogen Hldgs stock logo
BION
Bio Nitrogen Hldgs
N/AN/AN/AN/AN/A
JG Boswell stock logo
BWEL
JG Boswell
N/AN/AN/AN/AN/A
CERP
Cereplast
N/AN/AN/AN/AN/A
Clariant AG stock logo
CLZNF
Clariant
N/AN/AN/AN/AN/A
Nascent Biotech, Inc. stock logo
NBIO
Nascent Biotech
N/AN/AN/AN/AN/A

Ownership

Institutional Ownership

CompanyInstitutional Ownership
Bio Nitrogen Hldgs stock logo
BION
Bio Nitrogen Hldgs
N/A
JG Boswell stock logo
BWEL
JG Boswell
N/A
CERP
Cereplast
N/A
Clariant AG stock logo
CLZNF
Clariant
31.17%
Nascent Biotech, Inc. stock logo
NBIO
Nascent Biotech
N/A

Insider Ownership

CompanyInsider Ownership
Bio Nitrogen Hldgs stock logo
BION
Bio Nitrogen Hldgs
N/A
JG Boswell stock logo
BWEL
JG Boswell
N/A
CERP
Cereplast
N/A
Clariant AG stock logo
CLZNF
Clariant
N/A
Nascent Biotech, Inc. stock logo
NBIO
Nascent Biotech
N/A

Miscellaneous

CompanyEmployeesShares OutstandingFree FloatOptionable
Bio Nitrogen Hldgs stock logo
BION
Bio Nitrogen Hldgs
N/AN/AN/ANot Optionable
JG Boswell stock logo
BWEL
JG Boswell
N/AN/AN/ANot Optionable
CERP
Cereplast
N/AN/AN/ANot Optionable
Clariant AG stock logo
CLZNF
Clariant
10,481N/AN/ANot Optionable
Nascent Biotech, Inc. stock logo
NBIO
Nascent Biotech
4N/AN/ANot Optionable

NBIO, BION, BWEL, CERP, and CLZNF Headlines

SourceHeadline
Nascent Biotech (OTCMKTS:NBIO) Stock Crosses Below 50 Day Moving Average of $0.12Nascent Biotech (OTCMKTS:NBIO) Stock Crosses Below 50 Day Moving Average of $0.12
americanbankingnews.com - April 25 at 4:36 AM
Nascent Biotech prepares for pivotal Phase II research with fresh manufacturing runNascent Biotech prepares for pivotal Phase II research with fresh manufacturing run
msn.com - April 16 at 3:45 PM
Nascent Biotech Inc.: Nascent Prepares for Pivotal Phase II Research with Fresh Manufacturing RunNascent Biotech Inc.: Nascent Prepares for Pivotal Phase II Research with Fresh Manufacturing Run
finanznachrichten.de - April 16 at 8:23 AM
Nascent Prepares for Pivotal Phase II Research with Fresh Manufacturing RunNascent Prepares for Pivotal Phase II Research with Fresh Manufacturing Run
accesswire.com - April 16 at 8:00 AM
Nascent Biotech Inc.: Nascent Collaborates With Hypospray Pharma on Proprietary Transdermal Delivery SystemNascent Biotech Inc.: Nascent Collaborates With Hypospray Pharma on Proprietary Transdermal Delivery System
finanznachrichten.de - March 19 at 12:57 PM
Nascent Collaborates With Hypospray Pharma on Proprietary Transdermal Delivery SystemNascent Collaborates With Hypospray Pharma on Proprietary Transdermal Delivery System
accesswire.com - March 19 at 8:00 AM
Nascent Biotech Inc NBIONascent Biotech Inc NBIO
morningstar.com - March 2 at 2:35 PM
Nascent Biotech, Manhattan Bio collaborate to explore pritumumab antibody-drug conjugatesNascent Biotech, Manhattan Bio collaborate to explore pritumumab antibody-drug conjugates
pharmabiz.com - February 8 at 2:18 AM
Nascent Biotech Inc.: Nascent Biotech and Manhattan BioSolutions Collaborate to Explore Pritumumab Antibody-Drug ConjugatesNascent Biotech Inc.: Nascent Biotech and Manhattan BioSolutions Collaborate to Explore Pritumumab Antibody-Drug Conjugates
finanznachrichten.de - February 6 at 10:09 AM
Nascent Biotech and Manhattan BioSolutions Collaborate to Explore Pritumumab Antibody-Drug ConjugatesNascent Biotech and Manhattan BioSolutions Collaborate to Explore Pritumumab Antibody-Drug Conjugates
finance.yahoo.com - February 6 at 10:09 AM
Nascent Biotech Inc.: Nascent Biotech Receives an Analyst Opinion Suggesting that of the Company is Significantly Under ValuedNascent Biotech Inc.: Nascent Biotech Receives an Analyst Opinion Suggesting that of the Company is Significantly Under Valued
finanznachrichten.de - January 10 at 8:43 AM
Nascent Biotech Receives an Analyst Opinion Suggesting that of the Company is Significantly Under ValuedNascent Biotech Receives an Analyst Opinion Suggesting that of the Company is Significantly Under Valued
finance.yahoo.com - January 9 at 9:25 AM
Nascent Biotech Completes Payment of Variable Convertible Note in Full to Eliminate Dilution RiskNascent Biotech Completes Payment of Variable Convertible Note in Full to Eliminate Dilution Risk
finance.yahoo.com - December 19 at 12:10 PM
Nascent Biotech Granted Japanese Patent for Crossing Blood-Brain BarrierNascent Biotech Granted Japanese Patent for Crossing Blood-Brain Barrier
finance.yahoo.com - November 29 at 9:37 AM
West Coast investor Red Tree on its San Diego expansion and staying bullish in biotechWest Coast investor Red Tree on its San Diego expansion and staying bullish in biotech
biopharmadive.com - November 16 at 12:58 PM
Isana Nascent AcademyIsana Nascent Academy
usnews.com - November 15 at 8:20 PM
Concord Biotech hits record high after Jefferies initiates buy call; sees 19% upsideConcord Biotech hits record high after Jefferies initiates 'buy' call; sees 19% upside
moneycontrol.com - November 1 at 1:55 AM
Chicago to showcase its biotech sector at capital summit next weekChicago to showcase its biotech sector at capital summit next week
bizjournals.com - October 26 at 6:07 PM
A tropical storm could threaten Florida next week. Here’s what we know.A tropical storm could threaten Florida next week. Here’s what we know.
washingtonpost.com - September 2 at 5:04 AM
Nascent Biotech to Begin Phase II Clinical Trials for Brain CancerNascent Biotech to Begin Phase II Clinical Trials for Brain Cancer
finance.yahoo.com - August 22 at 8:18 AM
Nascent Project: Open Source Scanning Electron MicroscopeNascent Project: Open Source Scanning Electron Microscope
hackaday.com - July 21 at 8:09 PM
Nascent Biotech Inc.: Nascent Biotech Phase I Clinical Data Presented at the American Society of Clinical Oncology Annual MeetingNascent Biotech Inc.: Nascent Biotech Phase I Clinical Data Presented at the American Society of Clinical Oncology Annual Meeting
finanznachrichten.de - June 7 at 9:46 AM
Nascent Biotech Phase I Clinical Data Presented at the American Society of Clinical Oncology Annual MeetingNascent Biotech Phase I Clinical Data Presented at the American Society of Clinical Oncology Annual Meeting
bignewsnetwork.com - June 7 at 9:46 AM
Nascent Biotech Inc.: Nascent Biotech Regains Worldwide Rights for PritumumabNascent Biotech Inc.: Nascent Biotech Regains Worldwide Rights for Pritumumab
finanznachrichten.de - May 26 at 7:13 PM

New MarketBeat Followers Over Time

Media Sentiment Over Time

Company Descriptions

Bio Nitrogen Hldgs logo

Bio Nitrogen Hldgs

OTCMKTS:BION
BioNitrogen Holdings Corp. engages in the manufacture of fertilizers through the conversion of agricultural biomass. It focuses on building turnkey manufacturing facilities to produce urea fertilizer, urea ammonium nitrate, melamine, and diesel exhaust fluid. The company was founded by Mario G. Beruvides on September 16, 1990 and is headquartered in Doral, FL.
JG Boswell logo

JG Boswell

OTCMKTS:BWEL
JG Boswell Company produces, processes, and markets pima cotton. It is also involved in processing tomatoes for paste and seed crops, as well as livestock operations in Central California. The company was founded in 1925 and is headquartered in Pasadena, California.

Cereplast

OTCMKTS:CERP
Cereplast, Inc. designs and manufactures proprietary starch-based, and algae-based bio-plastic resins. Its bio-resins can replace a significant portion of the petroleum-based additives with bio-based material, such as starches from tapioca, corn, wheat and potatoes. The company was founded by Frederic Scheer on September 29, 2001 and is headquartered in Seymour, IN.
Clariant logo

Clariant

OTCMKTS:CLZNF
Clariant AG engages in the development, manufacture, distribution, and sale of specialty chemicals worldwide. The Care Chemicals segment offers specialty chemicals and application solutions for various applications in automotive fluids, aviation, construction chemicals, crop solutions, health care, home care, industrial lubricants, paints and coatings, personal care, and special solvents. The Catalysis segment provides catalyst products for use as ammonia cracking, ammonia, custom catalysts, ethylene and derivatives, fischer-tropsch, fuel cell, fuel upgrading, gas processing, hydrogen, hydrogenation, liquid hydrogen carrier, low-carbon ammonia, low-carbon methanol, methanol, methanol-to-propylene, off-gas treatment, olefins purification, on-purpose propylene, oxidation, polypropylene, refinery stream purification, styrene, zeolite powders, biocatalysis, cellulosic ethanol, cellulosic sugars, low-carbon advanced biofuels, and residue-derived biochemical intermediates. The Adsorbents and Additives segment provides chemicals for oil, gas, mining, and refinery industries; services for oil and gas industries; emulsifiers for explosives, as well as cold-flow additive applications for middle distillates in refineries; mineral-based specialty products for bio- and renewable fuel purification, BTX catalysts, cargo and device protection, cat litter, chemical recycling, civil engineering, clay specialties, detergent additives, edible oil purification, feed additives, foundry additives, kerosene and jet fuel purification, paper additives, PVC stabilizers, and wastewater treatment applications; and flame retardants, performance additives, and advanced surface solutions for use in acid scavengers, antioxidiants, antistatic agents, halogen-free flame retardants, heat stabilizers, hot-melt adhesives, light stabilizers, lubricants, processing aids, processing stabilizers, release agents, slip control agents, and surface modifiers. The company was founded in 1886 and is headquartered in Muttenz, Switzerland.
Nascent Biotech logo

Nascent Biotech

OTCMKTS:NBIO
Nascent Biotech, Inc., a clinical-stage biopharmaceutical company, develops monoclonal antibodies for the treatment of various forms of cancer. It is developing Pritumumab, a drug to treat patients with brain cancer malignancies, such as glioblastoma and malignant astrocytoma, as well as epithelial cancers, including lung, breast, colon, brain, and pancreas cancer. The company is developing MultiPharm, a proprietary technology platform for cancer therapy, as well as diabetes, autoimmunity, and transplantation. In addition, it develops CLNH5. The company has collaboration with Hypospray Pharma to develop an alternative delivery mechanism for patients who can benefit from Pritumumab. Nascent Biotech, Inc. is based in North Palm Beach, Florida.